Liz is an experienced research scientist who was a member of the P2Y₁₂ antagonist project team at AstraZeneca that lead to the discovery of Brilinta (ticagrelor) and Kengreal (cangrelor).

Subsequently, she worked across a range of projects in BioScience, combining target identification and validation activities with disease knowledge within the respiratory and inflammation research area.

At XenoGesis she combined data/documentation quality control with drug discovery expertise and supported Business Development.

Liz has joined Platelet Services in 2023 to enhance the data management services.